Product
Tenofovir disoproxil
Aliases
Tenofovir disoproxil fumarate
9 clinical trials
4 indications
Indication
Hepatitis BIndication
ChronicIndication
HIV-1Indication
Hepatitis DClinical trial
A Phase 2, Open-label, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Patients With Chronic Hepatitis B Virus InfectionStatus: Terminated, Estimated PCD: 2021-12-29
Clinical trial
A Phase 2 Randomized, Open-label, Parallel-group, Multicenter Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Response to Combination Regimens Containing JNJ-73763989 and Nucleos(t)Ide Analog With or Without JNJ-56136379 in Patients With Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2023-02-08
Clinical trial
A Phase 2, Randomized, Open-label, Multicenter Study to Evaluate Efficacy, Pharmacokinetics, Safety, and Tolerability of Treatment With JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog With or Without JNJ-56136379 in Treatment-naive Patients With HBeAg Positive Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2023-08-29
Clinical trial
A Phase II, Open Label, Single Arm Trial to Evaluate the Pharmacokinetics,Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Antiretroviral Naive HIV-1 Infected Adolescents and Children Aged >= 6 to <18 YearsStatus: Completed, Estimated PCD: 2022-08-16
Clinical trial
A Phase 2, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Patients With Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2022-05-16
Clinical trial
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East AfricaStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
The Use of Tenofovir Disoproxil Fumarate (TDF) in the Management of Patients With Inactive Chronic Hepatitis B (CHB) InfectionStatus: Completed, Estimated PCD: 2023-02-28
Clinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled Study With Deferred Active Treatment to Investigate the Efficacy, Safety, and Pharmacokinetics of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusStatus: Active (not recruiting), Estimated PCD: 2023-10-19
Clinical trial
A Phase 1b, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Treatment With JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, HBeAg-negative Participants With Chronic Hepatitis B Virus InfectionStatus: Active (not recruiting), Estimated PCD: 2023-07-31